Infantile status epilepticus disrupts myelin development.


Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
01 2022
Historique:
received: 27 07 2021
revised: 12 11 2021
accepted: 23 11 2021
pubmed: 29 11 2021
medline: 8 4 2022
entrez: 28 11 2021
Statut: ppublish

Résumé

Temporal lobe epilepsy (TLE) is the most prevalent type of epilepsy in adults; it often starts in infancy or early childhood. Although TLE is primarily considered to be a grey matter pathology, a growing body of evidence links this disease with white matter abnormalities. In this study, we explore the impact of TLE onset and progression in the immature brain on white matter integrity and development utilising the rat model of Li-pilocarpine-induced TLE at the 12th postnatal day (P). Diffusion tensor imaging (DTI) and Black-Gold II histology uncovered disruptions in major white matter tracks (corpus callosum, internal and external capsules, and deep cerebral white matter) spreading through the whole brain at P28. These abnormalities were mostly not present any longer at three months after TLE induction, with only limited abnormalities detectable in the external capsule and deep cerebral white matter. Relaxation Along a Fictitious Field in the rotating frame of rank 4 indicated that white matter changes observed at both timepoints, P28 and P72, are consistent with decreased myelin content. The animals affected by TLE-induced white matter abnormalities exhibited increased functional connectivity between the thalamus and medial prefrontal and somatosensory cortex in adulthood. Furthermore, histological analyses of additional animal groups at P15 and P18 showed only mild changes in white matter integrity, suggesting a gradual age-dependent impact of TLE progression. Taken together, TLE progression in the immature brain distorts white matter development with a peak around postnatal day 28, followed by substantial recovery in adulthood. This developmental delay might give rise to cognitive and behavioural comorbidities typical for early-onset TLE.

Identifiants

pubmed: 34838665
pii: S0969-9961(21)00315-6
doi: 10.1016/j.nbd.2021.105566
pmc: PMC8845085
mid: NIHMS1775908
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105566

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB027061
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2010 Dec 23;363(26):2522-9
pubmed: 21175314
Epilepsia. 1995 Oct;36(10):973-82
pubmed: 7555961
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Magn Reson Imaging. 2002 Sep;20(7):511-9
pubmed: 12413596
Brain Res. 2008 Sep 10;1229:210-7
pubmed: 18657520
Brain Connect. 2013;3(1):22-30
pubmed: 23150897
Magn Reson Imaging. 2011 Dec;29(10):1346-50
pubmed: 21601405
Dev Cell. 2015 Feb 23;32(4):447-58
pubmed: 25710531
Exp Neurol. 2019 Oct;320:113005
pubmed: 31278943
Magn Reson Med. 2010 Oct;64(4):983-94
pubmed: 20740665
Epilepsy Res. 2008 Jul;80(1):30-41
pubmed: 18436432
Neuroscience. 2014 Sep 12;276:126-34
pubmed: 23820043
Epilepsy Res. 2008 Oct;81(2-3):128-35
pubmed: 18595664
Eur J Neurosci. 2004 Jun;19(12):3255-65
pubmed: 15217382
J Neurosci Methods. 2009 Dec 15;185(1):15-22
pubmed: 19737577
Front Neurosci. 2017 Aug 03;11:433
pubmed: 28824359
Epilepsia. 2011 Apr;52(4):841-5
pubmed: 21366557
Epilepsia. 2014 Jan;55(1):137-45
pubmed: 24313597
Brain Res. 2015 Nov 19;1627:154-64
pubmed: 26433043
Neuroimage. 2017 May 15;152:221-236
pubmed: 28267625
Brain Res. 2018 Oct 1;1696:71-80
pubmed: 29772217
Neuroimage. 2009 Jul 1;46(3):569-76
pubmed: 19289170
Neural Plast. 2014;2014:675128
pubmed: 24778885
Magn Reson Med. 2016 Jan;75(1):161-8
pubmed: 25648507
PLoS One. 2008 Apr 16;3(4):e2004
pubmed: 18414674
Magn Reson Imaging. 1998 Nov;16(9):1033-41
pubmed: 9839987
Hum Brain Mapp. 2013 Sep;34(9):2202-16
pubmed: 22505284
Toxicol Pathol. 2014 Jul;42(5):913-22
pubmed: 24129760
Magn Reson Med. 1994 Jun;31(6):673-7
pubmed: 8057820
Nat Neurosci. 2013 Dec;16(12):1888-1895
pubmed: 24141310
Nat Rev Neurol. 2016 Aug;12(8):465-76
pubmed: 27448186
Neuroscience. 2013 Apr 3;235:232-49
pubmed: 23305765
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Neuroimage. 2005 May 15;26(1):132-40
pubmed: 15862213
Brain. 2016 Sep;139(Pt 9):2431-40
pubmed: 27357350
Eur J Radiol. 2017 Sep;94:53-57
pubmed: 28941760
Brain. 2012 Aug;135(Pt 8):2337-49
pubmed: 22734123
Epilepsia. 2017 Jan;58(1):113-122
pubmed: 27864929
Curr Opin Neurol. 2008 Aug;21(4):424-30
pubmed: 18607202
Neuroimage Clin. 2014 Mar 31;4:641-8
pubmed: 24936415
Dev Neurobiol. 2018 Feb;78(2):123-135
pubmed: 28986960
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
J Neurosurg Pediatr. 2018 Sep;22(3):270-275
pubmed: 29932365
PLoS One. 2014 Aug 22;9(8):e105521
pubmed: 25148080
J Magn Reson B. 1994 Mar;103(3):247-54
pubmed: 8019776
Epilepsia. 2002 Sep;43(9):1062-71
pubmed: 12199732
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Brain Struct Funct. 2011 Jun;216(2):123-35
pubmed: 21225282
Front Neurol. 2014 Jul 04;5:93
pubmed: 25071695
Brain Res. 2013 Jul 19;1522:76-87
pubmed: 23727401
Am J Physiol. 1971 Feb;220(2):333-6
pubmed: 5540880
J Neurosci. 2012 Aug 15;32(33):11259-70
pubmed: 22895710
Front Neurosci. 2021 Mar 04;15:625167
pubmed: 33746698
J Neurol. 2003 Nov;250(11):1293-301
pubmed: 14648144
Magn Reson Med. 1999 Sep;42(3):526-40
pubmed: 10467297
Eur J Neurosci. 2002 Aug;16(3):501-13
pubmed: 12193194
Handb Clin Neurol. 2016;138:159-71
pubmed: 27637958
Epilepsia. 2006 Jan;47(1):167-75
pubmed: 16417545
J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):312-9
pubmed: 18977826
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Neuroimage Clin. 2016 Nov 03;13:70-81
pubmed: 27942449
J Clin Neurophysiol. 1992 Apr;9(2):264-77
pubmed: 1350593
Nat Neurosci. 2013 Jan;16(1):64-70
pubmed: 23143518
Neuron. 2006 Sep 7;51(5):527-39
pubmed: 16950152
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Epilepsia. 2006 Mar;47(3):479-88
pubmed: 16529609
Epilepsia. 2011 Jul;52 Suppl 4:32-4
pubmed: 21732939
Hum Brain Mapp. 2017 Feb;38(2):938-956
pubmed: 27739612
PLoS One. 2015 Feb 13;10(2):e0116788
pubmed: 25680196
Epilepsia. 2021 Mar;62(3):583-595
pubmed: 33493363
Magn Reson Med. 2015 Jan;73(1):254-62
pubmed: 24523028
eNeuro. 2018 Oct 25;5(5):
pubmed: 30406193

Auteurs

Petra Bencurova (P)

CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; Department of Neurology, St. Anne's University Hospital and Medical Faculty of Masaryk University, Pekarska 53, 656 91 Brno, Czech Republic. Electronic address: petra.bencurova@ceitec.muni.cz.

Hanne Laakso (H)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Raimo A Salo (RA)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Ekaterina Paasonen (E)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Eppu Manninen (E)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Jaakko Paasonen (J)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Shalom Michaeli (S)

Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN, United States.

Silvia Mangia (S)

Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN, United States.

Martin Bares (M)

Department of Neurology, St. Anne's University Hospital and Medical Faculty of Masaryk University, Pekarska 53, 656 91 Brno, Czech Republic; Department of Neurology, School of Medicine, University of Minnesota, Minneapolis, MN, United States.

Milan Brazdil (M)

CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; Department of Neurology, St. Anne's University Hospital and Medical Faculty of Masaryk University, Pekarska 53, 656 91 Brno, Czech Republic.

Hana Kubova (H)

Academy of Sciences Czech Republic, Institute of Physiology, Department of Developmental Epileptology, Videnska 1083, 14220 Prague, Czech Republic. Electronic address: Hana.Kubova@fgu.cas.cz.

Olli Gröhn (O)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH